MedPath
NMPA Approval

Cefdinir Granules

国药准字H20253773

April 1, 2025

Drug Information

头孢地尼颗粒

颗粒剂

50mg

化学药品

April 1, 2025

Company Information

Applicant Company

重庆市南岸区江峡路1号10幢

Manufacturing Company

成都市武科东三路12号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.